The catastrophic summer of cannabis producer CannTrust Holdings (NYSE:CTST,TSX:TRST) continues as another provincial distributor says no more to its products.
On Thursday (September 19), the Ontario-based marijuana firm confirmed that the Alberta Gaming, Liquor and Cannabis Commission (AGLC) will be returning C$1.3 million worth of its products. CannTrust told investors the products will be returned under the terms of a cannabis supply agreement, which dictates that items sold to the AGLC can be returned at the expense of the company.
Health Canada discovered previously that CannTrust had been growing cannabis illegally in unlicensed rooms at its facility in Pelham, Ontario.
The firm noted that the AGLC works independently of Health Canada, and the federal regulator has not ordered a complete recall of its products. However, Alberta’s cannabis distribution agency has now followed in the footsteps of Ontario’s similar decision.
A representative from the AGLC said in an email to the Investing News Network (INN) that the return of these products, which include dried flower and cannabis oils, is directly related to the CannTrust license suspension. The spokesperson added, “(The AGLC) would consider stocking CannTrust product in the future should Health Canada reinstate its license.”
The decision from Alberta follows shortly after CannTrust got its license suspended from Health Canada on Tuesday (September 17).
In an email, a spokesperson for CannTrust said, “(The company’s priority is to) satisfy regulators that the Company meets or exceeds all regulatory requirements so it is in a position to resume operations and to regain the trust and confidence of shareholders, patients, customers and partners.”
The license suspension prevents the firm from producing, processing and selling cannabis, but leaves CannTrust’s ability to cultivate and harvest existing cannabis yields and conduct ancillary activities.
CannTrust told investors that Health Canada will reinstate the licenses once it fully deals with the reasons behind the suspension. The firm is on a timeline of 10 days, following the suspension, to answer the comments from the federal regulator.
As mentioned, Alberta has joined Ontario in returning products to the firm. In August, the Ontario Cannabis Store (OCS) notified CannTrust of a product return of C$2.9 million worth of what the OCS called “non-conforming products.”
A spokesperson for the OCS told INN that the retirement of the marijuana products was done “consistent with the OCS’ obligation to operate its business in a responsible manner.”
Fortunes for the once-promising company, and its investors, turned sour when the federal regulator found its facility in Pelham to be non-compliant for growing cannabis in unlicensed rooms back in July. Since then, shares have dropped over 60 percent in value.
CannTrust’s previous year-to-date high was C$15.50, but shares opened at C$1.72 on Thursday.
After the non-compliant rating, thousands of kilograms of the company’s products were put on hold, Ontario and Alberta both pulled stock from shelves and CannTrust’s Danish partner put the company’s stock under quarantine until the matter was resolved.
In response to the growing scandal, CannTrust fired then-CEO Peter Aceto and forced former chairman Eric Paul to resign after a report from the Globe and Mail found the two men, along with other high-level executives, were aware of the illegal growing.
Matters were made worse when it was revealed executives asked employees to hang false walls to hide the rooms in question during routine inspections from Health Canada. Aceto was replaced by Robert Marcovitch as interim CEO.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).